Table 1 Demographic and laboratory data
|  | All (n = 1057) | Mortality (−) (n = 982) | Mortality (+) (n = 75) | p value |
|---|---|---|---|---|
Demographic data | ||||
 Age (years) | 60.5 ± 13.1 | 59.7 ± 12.9 | 70.8 ± 11.0 | < 0.001 |
 Men [n (%)] | 837 (79.2) | 784 (79.8) | 53 (70.7) | 0.075 |
 Body mass index (kg/m2) | 24.1 ± 3.2 | 24.2 ± 3.2 | 23.0 ± 3.6 | 0.002 |
 Diabetes mellitus [n (%)] | 279 (26.4) | 250 (25.5) | 29 (38.7) | 0.020 |
 Hypertension [n (%)] | 496 (46.9) | 452 (46.0) | 44 (58.7) | 0.041 |
 Systolic blood pressure (mmHg) | 125.1 ± 27.3 | 126.3 ± 26.7 | 109.0 ± 30.8 | < 0.001 |
 Diastolic blood pressure (mmHg) | 76.3 ± 17.5 | 77.0 ± 17.2 | 66.9 ± 19.2 | < 0.001 |
 Heart rate (beats/minute) | 77.5 ± 20.1 | 76.7 ± 19.5 | 87.3 ± 25.0 | 0.001 |
 Cardiogenic shock [n (%)] | 66 (6.2) | 47 (4.8) | 19 (25.3) | < 0.001 |
 Killip class II–IV [n (%)] | 209 (19.8) | 168 (17.1) | 41 (54.7) | < 0.001 |
 Anterior wall infarction [n (%)] | 564 (69.3) | 512 (52.1) | 52 (69.3) | 0.004 |
Laboratory data | ||||
 Albumin (g/dL) | 4.2 ± 0.4 | 4.2 ± 0.4 | 3.8 ± 0.6 | < 0.001 |
 Glucose (mg/dL) | 177.7 ± 83.1 | 173.0 ± 74.6 | 239.4 ± 144.0 | < 0.001 |
 Dysglycemia [n (%)] | 159 (15.0) | 126(12.8) | 33 (44.0) | < 0.001 |
 Total bilirubin (mg/dL) | 0.7 ± 0.4 | 0.7 ± 0.4 | 0.7 ± 0.5 | 0.245 |
 AST (IU/L) | 33.0 (23.0–65.0) | 32.0 (23.0–61.0) | 72.0 (27.0–227.0) | < 0.001 |
 ALT (IU/L) | 26.0 (19.0–42.0) | 26.0 (19.0–41.0) | 36.0 (18.0–78.0) | 0.034 |
 Hypoxic liver injury†[n (%)] | 236 (22.3) | 199 (20.3) | 37 (49.3) | < 0.001 |
 ALP (IU/L) | 74.0 (61.0–91.1) | 74.0 (61.0–90.0) | 81.0 (65.0–98.0) | 0.061 |
 Creatinine (mg/dL) | 1.08 ± 0.73 | 1.06 ± 0.73 | 1.33 ± 0.67 | 0.001 |
 Estimated GFR (mL/min/1.73 m2) | 82.1 ± 27.5 | 83.3 ± 26.8 | 65.8 ± 32.0 | < 0.001 |
 Estimated GFR < 60 mL/min/1.73 m2 [n (%)] | 184 (17.4) | 152 (15.5) | 32 (42.7) | < 0.001 |
 Hemoglobin (mg/dL) | 14.2 ± 1.9 | 14.3 ± 1.9 | 13.1 ± 2.4 | < 0.001 |
 Anemia [n (%)] | 177 (16.7) | 146 (14.9) | 31 (41.3) | < 0.001 |
 WBC (× 103/µL) | 12.0 ± 5.2 | 11.8 ± 5.2 | 13.9 ± 4.7 | 0.001 |
 NLR | 3.1 (1.6–5.7) | 3.0 (1.5–5.4) | 5.4 (3.0–8.9) | < 0.001 |
 NLR > 4.3 [n (%)] | 393 (37.2) | 342 (34.8) | 51 (68.0) | < 0.001 |
 Total cholesterol (mg/dL) | 189.3 ± 43.7 | 190.6 ± 43.1 | 172.5 ± 47.8 | 0.001 |
 LDL-cholesterol (mg/dL) | 117.0 ± 36.8 | 117.8 ± 36.7 | 106.6 ± 37.0 | 0.043 |
 HDL-cholesterol (mg/dL) | 42.5 ± 11.0 | 42.6 ± 10.9 | 41.0 ± 11.7 | 0.305 |
 Triglyceride | 129.0 (86.0–196.0) | 131.0 (87.0–197.0) | 111.0 (76.5–180.5) | 0.100 |
 Initial CK-MB (ng/mL) | 5.3 (2.1–26.5) | 4.9 (2.1–22.5) | 26.0 (3.6–96.1) | < 0.001 |
 Peak CK-MB (ng/mL) | 177.4 (78.2–300.0) | 170.9 (77.8–300.0) | 271.0 (86.0–332.2) | 0.016 |